Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation

The human voltage gated potassium channel Kv1.5 that conducts the I(Kur) current is a key determinant of the atrial action potential. Its mutations have been linked to hereditary forms of atrial fibrillation (AF), and the channel is an attractive target for the management of AF. The development of I...

Descripción completa

Detalles Bibliográficos
Autores principales: Borrego, Jesús, Feher, Adam, Jost, Norbert, Panyi, Gyorgy, Varga, Zoltan, Papp, Ferenc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704205/
https://www.ncbi.nlm.nih.gov/pubmed/34959701
http://dx.doi.org/10.3390/ph14121303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704205/
https://www.ncbi.nlm.nih.gov/pubmed/34959701
http://dx.doi.org/10.3390/ph14121303

Ejemplares similares